Sithu Shein A, Hongsing P, Khatib A, Phattharapornjaroen P, Miyanaga K, Cui L
NPJ Antimicrob Resist. 2025; 2(1):31.
PMID: 39843534
PMC: 11721074.
DOI: 10.1038/s44259-024-00045-4.
Victoria-Blanco E, Gonzalez-Gomez J, Medina-Sanchez J, Martinez A, Castro Del Campo N, Chaidez-Quiroz C
PLoS One. 2024; 19(12):e0310824.
PMID: 39739645
PMC: 11687723.
DOI: 10.1371/journal.pone.0310824.
Palma M, Qi B
Infect Dis Rep. 2024; 16(6):1127-1181.
PMID: 39728014
PMC: 11675988.
DOI: 10.3390/idr16060092.
Van Overfelt S, Duyvejonck H, Baeke F, De Rycke R, Merabishvili M, Vermeulen S
PLoS One. 2024; 19(12):e0313774.
PMID: 39625917
PMC: 11614264.
DOI: 10.1371/journal.pone.0313774.
Bennett A, Laipply B, Gunn J
Access Microbiol. 2024; 6(11).
PMID: 39619287
PMC: 11605878.
DOI: 10.1099/acmi.0.000913.v3.
Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa bacteriophage therapy for cystic fibrosis.
Harker S, Preissner M, Chang R, Trevascus D, Liu C, Wang Y
Sci Rep. 2024; 14(1):29727.
PMID: 39614107
PMC: 11607086.
DOI: 10.1038/s41598-024-80326-0.
Prediction of strain level phage-host interactions across the Escherichia genus using only genomic information.
Gaborieau B, Vaysset H, Tesson F, Charachon I, Dib N, Bernier J
Nat Microbiol. 2024; 9(11):2847-2861.
PMID: 39482383
DOI: 10.1038/s41564-024-01832-5.
The Potential of Phage Treatment to Inactivate Planktonic and Biofilm-Forming .
Martinho I, Braz M, Duarte J, Bras A, Oliveira V, Gomes N
Microorganisms. 2024; 12(9).
PMID: 39338470
PMC: 11433742.
DOI: 10.3390/microorganisms12091795.
Multi-strain phage induced clearance of bacterial infections.
Marchi J, Minh C, Debarbieux L, Weitz J
bioRxiv. 2024; .
PMID: 39282405
PMC: 11398464.
DOI: 10.1101/2024.09.07.611814.
Metapopulation model of phage therapy of an acute lung infection.
Rodriguez-Gonzalez R, Balacheff Q, Debarbieux L, Marchi J, Weitz J
mSystems. 2024; 9(10):e0017124.
PMID: 39230264
PMC: 11562898.
DOI: 10.1128/msystems.00171-24.
Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections.
Siopi M, Skliros D, Paranos P, Koumasi N, Flemetakis E, Pournaras S
Clin Microbiol Rev. 2024; 37(3):e0004424.
PMID: 39072666
PMC: 11391690.
DOI: 10.1128/cmr.00044-24.
Phage therapy: breathing new tactics into lower respiratory tract infection treatments.
Vaezi A, Healy T, Ebrahimi G, Rezvankhah S, Hashemi Shahraki A, Mirsaeidi M
Eur Respir Rev. 2024; 33(172).
PMID: 38925791
PMC: 11216685.
DOI: 10.1183/16000617.0029-2024.
Metapopulation model of phage therapy of an acute lung infection.
Rodriguez-Gonzalez R, Balacheff Q, Debarbieux L, Marchi J, Weitz J
bioRxiv. 2024; .
PMID: 38352502
PMC: 10862780.
DOI: 10.1101/2024.01.31.578251.
Macrophage-induced reduction of bacteriophage density limits the efficacy of pulmonary phage therapy.
Zborowsky S, Seurat J, Balacheff Q, Ecomard S, Minh C, Titecat M
bioRxiv. 2024; .
PMID: 38293203
PMC: 10827109.
DOI: 10.1101/2024.01.16.575879.
The Respiratory Microbiome in Paediatric Chronic Wet Cough: What Is Known and Future Directions.
Atto B, Anteneh Y, Bialasiewicz S, Binks M, Hashemi M, Hill J
J Clin Med. 2024; 13(1).
PMID: 38202177
PMC: 10779485.
DOI: 10.3390/jcm13010171.
Isolation of temperate bacteriophage with broad killing activity to clinical isolates.
Sugai K, Kawada-Matsuo M, Le M, Sugawara Y, Hisatsune J, Fujiki J
iScience. 2023; 26(12):108465.
PMID: 38089578
PMC: 10713843.
DOI: 10.1016/j.isci.2023.108465.
Human Neutrophil Response to Bacteriophage PAK_P1, a Therapeutic Candidate.
Roach D, Noel B, Chollet-Martin S, de Jode M, Granger V, Debarbieux L
Viruses. 2023; 15(8).
PMID: 37632068
PMC: 10458410.
DOI: 10.3390/v15081726.
Characterization of novel bacteriophage PSKP16 and its therapeutic potential against β-lactamase and biofilm producer strain of K2-Hypervirulent Klebsiella pneumoniae pneumonia infection in mice model.
Rahimi S, Bakht M, Javadi A, Foroughi F, Marashi S, Nikkhahi F
BMC Microbiol. 2023; 23(1):233.
PMID: 37612659
PMC: 10464470.
DOI: 10.1186/s12866-023-02979-7.
Virus-pathogen interactions improve water quality along the Middle Route of the South-to-North Water Diversion Canal.
Chen T, Liu T, Wu Z, Wang B, Chen Q, Zhang M
ISME J. 2023; 17(10):1719-1732.
PMID: 37524909
PMC: 10504254.
DOI: 10.1038/s41396-023-01481-2.
Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?.
Ling K, Stick S, Kicic A
Front Med (Lausanne). 2023; 10:1088494.
PMID: 37265479
PMC: 10230084.
DOI: 10.3389/fmed.2023.1088494.